Heart device study aims to cut unnecessary doctor visits

NCT ID NCT07352657

Not yet recruiting Disease control Sponsor: Beth Israel Deaconess Medical Center Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tests whether using alerts from pacemakers and defibrillators to guide care is as safe and more effective than following standard schedules. About 3,000 adults with wireless heart devices will be randomly assigned to either alert-driven care or guideline-based care. The goal is to see if the alert approach reduces serious heart events and makes each doctor visit more useful.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Alert-based care (remote monitoring strategy)
What this could lead to: If successful, this could make managing heart devices more efficient, reducing hospital visits and catching problems earlier.
What could go wrong: This is a pragmatic trial comparing care strategies, not testing a new drug or device. The benefit may be modest, and results depend on real-world implementation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for IMPLANTABLE DEFIBRILLATOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

IMPLANTABLE DEFIBRILLATOR PACEMAKER

Contacts and locations

Locations

Beth Israel Deaconess Medical Center

Boston, Massachusetts, 02215, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.